Losartan as disease modulating therapy for recessive dystrophic epidermolysis bullosa

A 6-year-old child with recessive dystrophic epidermolysis bullosa, confirmed by history, clinical exam, and antigen mapping, was treated with losartan with reduction in the blistering and better quality of life.